1. Carskadon MA, Dement WC. Normal Human Sleep: An Overview. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: W.B. Saunders; 2005:13–23.

2. Curcio G, Casagrande M, Bertini M. Sleepiness: evaluating and quantifying methods. Int J Psychophysiol. 2001;41(3):251–263.

3. Bagai K, Malow BA. A novel approach to treating morning sleep inertia in narcolepsy. J Clin Sleep Med. 2010;6(1):77–78.

4. Trotti LM, Ong J, Plante D, Powell D, Bliwise DL. Self-reported sleep inertia in the Hypersomnia Foundation registry, Sleep. 2018;41(4_suppl_1):A228–A229.

5. Nigam M, Hippolyte A, Dodet P, et al.. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. J Clin Sleep Med. 2022;18(1):255–263.

6. Vernet C, Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep. 2009;32(6):753–759.

7. Landzberg D, Trotti LM. Is idiopathic hypersomnia a circadian rhythm disorder? Curr Sleep Med Rep. 2019;5(4):201–206.

8. Schirmacher A, Hor H, Heidbreder A, et al.. Sequence variants in circadian rhythmic genes in a cohort of patients suffering from hypersomnia of central origin. Biol Rhythm Res. 2011;42(5):407–416.

9. Lippert J, Halfter H, Heidbreder A, et al.. Altered dynamics in the circadian oscillation of clock genes in dermal fibroblasts of patients suffering from idiopathic hypersomnia. PLoS One. 2014;9(1):e85255.

10. Möller-Levet CS, Archer SN, Bucca G, et al.. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA. 2013;110(12):E1132–E1141.

11. Barateau L, Lopez R, Dauvilliers Y. Treatment options for narcolepsy. CNS Drugs. 2016;30(5):369–379.

12. Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol Clin Exp. 2004;19(3):151–180.

13. Marín Agudelo HA, Jiménez Correa U, Carlos Sierra J, Pandi-Perumal SR, Schenck CH. Cognitive behavioral treatment for narcolepsy: can it complement pharmacotherapy? Sleep Sci. 2014;7(1):30–42.

14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

15. Akram U. A patient’s view on reclassifying idiopathic hypersomnia to narcolepsy type-3. Sleep . 2020;43(10):zsaa134.

16. Takahashi M. The role of prescribed napping in sleep medicine. Sleep Med Rev. 2003;7(3):227–235.

17. Hirshkowitz M, Sharafkhaneh A. Fatigue Management. In: Hirshkowitz M, Sharafkhaneh A, eds. Fatigue Management. New York: Springer; 2018:193–217,

18. Alger SE, Brager AJ, Capaldi VF. Challenging the stigma of workplace napping. Sleep. 2019;42(8):zsz097.

19. Kapella MC, Berger BE, Vern BA, Vispute S, Prasad B, Carley DW. Health-related stigma as a determinant of functioning in young adults with narcolepsy. PLoS One. 2015;10(4):e0122478.

20. Wasling HB, Bornstein A, Wasling P. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study. Sleep Med. 2020;76:104–112.